Organism name | Cocculus laurifolius DC. |
---|---|
Genus | Cocculus |
Family | Menispermaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Cocculus laurifolius |
---|---|
Linked NCBI taxonomy ID | 152359 |
Linked level | species |
Family in NCBI taxonomy | Menispermaceae |
---|---|
ID | 3455 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | eudicotyledons |
---|---|
ID | 71240 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00025653
![]() |
Efirine
/ Cocsulin / (+)-Efirine / Trigilletine / (+)-Cocsuline / (+)-Trigilletine |
CHEMBL447886
CHEMBL2063766 |
No. 10 | No. 4 |
![]() |
|||
C00025313
![]() |
Isotetrandrine
/ Isosinomenine A / O-Methylberbamine / O,O-Dimethylobamegine / O,O'-Dimethylobamegine / O,O-Dimethylstepholine / O,O'-Dimethylstepholine |
CHEMBL176045
CHEMBL367260 CHEMBL445477 CHEMBL449690 CHEMBL504958 CHEMBL504757 |
26 / 23 / 48 | No. 10 | No. 4 |
![]() |
||
C00025962
![]() |
Norisoboldine
/ Laurelliptine / (+)-Norisoboldine / (+)-Laurelliptine / (+)-N-Norisoboldine / (S)-(+)-Laurelliptine |
CHEMBL375902
|
No. 20 | No. 4 |
![]() |
|||
C00026094
![]() |
Stepholidine
/ (-)-Stepholidine |
CHEMBL487387
CHEMBL2334890 |
C010513
|
7 / 4 / 0 | 0 / 1 | No. 37 | No. 4 |
![]() |
C00026102
![]() |
(+)-Sinactine
|
No. 37 | No. 4 |
![]() |
||||
C00025812
![]() |
Coclaurine
/ (S)-Coclaurine / (-)-Coclaurine |
CHEMBL256448
CHEMBL453291 CHEMBL446211 |
C004690
|
8 / 17 / 10 | No. 253 | No. 4 |
![]() |
|
C00025869
![]() |
Erythramide
|
No. 273 | No. 4 |
![]() |
||||
C00025868
![]() |
Erythlaurine
|
No. 273 | No. 4 |
![]() |
||||
C00025850
![]() |
Dihydroerysodine
|
No. 273 | No. 4 |
![]() |
||||
C00025870
![]() |
Erythroculine
|
No. 273 | No. 4 |
![]() |
||||
C00025807
![]() |
Cocculitinine
|
No. 273 | No. 4 |
![]() |
||||
C00025802
![]() |
Cocculidine
|
C015083
|
No. 273 | No. 4 |
![]() |
|||
C00025805
![]() |
Kokuline
/ Cocculine / (+)-Coculine |
No. 273 | No. 4 |
![]() |
||||
C00025806
![]() |
Cocculitine
|
No. 273 | No. 4 |
![]() |
||||
C00024888
![]() |
Garryfoline
/ Laurifoline / 15-Epiveatchine / (20S)-Garryfoline |
No. 274 | No. 10 |
![]() |
||||
C00025667
![]() |
(+)-Laurifoline
|
CHEMBL235429
|
No. 286 | No. 4 |
![]() |
|||
C00025674
![]() |
N-Methylcorydine
/ (+)-N-Methylcorydine |
CHEMBL1617951
|
No. 286 | No. 4 |
![]() |
|||
C00001918
![]() |
Cucoline
/ Kukoline / Sinomenine |
CHEMBL248095
CHEMBL1551847 CHEMBL1555036 CHEMBL1589951 CHEMBL1591798 |
C009271
|
9 / 8 / 8 | No. 346 | No. 4 |
![]() |
|
C00025988
![]() |
Sebiferine
/ (9R)-Sebiferine / O-Methylflavinantine / (+)-O-Methylflavinanthine / (+)-O-Methylflavinantine |
CHEMBL224744
CHEMBL490139 |
C024736
|
No. 426 | No. 4 |
![]() |
||
C00025810
![]() |
Coccuvine
|
C013447
|
No. 446 | No. 4 |
![]() |
|||
C00025811
![]() |
Coccuvinine
/ O-Methylcoccuvine |
No. 446 | No. 4 |
![]() |
||||
C00025272
![]() |
Stepharine
/ (+)-Stepharine |
CHEMBL463957
CHEMBL1975436 |
C009320
|
No. 688 |
![]() |
|||
C00001905
![]() |
Milthanthine
/ Pronuciferine / (+)-Pronuciferine / N-Methylstepharine / N,O-Dimethylcrotonosine |
CHEMBL237766
|
No. 688 |
![]() |
||||
C00025799
![]() |
Coccoline
|
No. 948 |
![]() |
|||||
C00025800
![]() |
Coccolinine
/ O-Methylcoccoline |
No. 948 |
![]() |
|||||
C00025925
![]() |
Laurifinine
|
No. 2029 |
![]() |
|||||
C00025926
![]() |
Laurifonine
/ (+/-)-Laurifonine |
No. 2029 |
![]() |
|||||
C00025904
![]() |
Isococculine
|
No. 3755 | No. 4 |
![]() |
||||
C00025804
![]() |
Cocculimine
|
No. 3755 | No. 4 |
![]() |
||||
C00025803
![]() |
Cocculidinone
|
No. 4375 |
![]() |
|||||
C00025801
![]() |
Coccudienone
|
No. 4375 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001918 C00025313 | 1 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001918 C00025812 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00001918 C00025812 | 4 / 3 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001918 C00025313 | 0 / 1 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001918 C00025313 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00025313 C00025812 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00025313 | 0 / 0 |
P01375 | Tumor necrosis factor | Secreted protein | C00001918 | 3 / 4 |
P04062 | Glucosylceramidase | Enzyme | C00025812 | 6 / 4 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00025313 | 0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00025313 | 0 / 0 |
P21918 | D(1B) dopamine receptor | Dopamine receptor | C00026094 | 1 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00025313 | 1 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00001918 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00025313 | 0 / 1 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00026094 | 2 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00025313 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00025313 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001918 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00025313 | 2 / 0 |
P14618 | Pyruvate kinase PKM | Enzyme | C00025812 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00026094 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00026094 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00025812 | 7 / 3 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001918 | 0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00025313 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00025313 | 1 / 1 |
P13726 | Tissue factor | Membrane receptor | C00026094 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00025313 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00025313 | 1 / 1 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00026094 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00025313 | 1 / 1 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00025313 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00025313 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00025313 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00025313 | 4 / 1 |
P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00026094 | 1 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00025313 | 7 / 37 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00025812 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00025313 | 1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00025313 | 1 / 0 |
O00255 | Menin | Unclassified protein | C00025313 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00025313 | 1 / 2 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00025812 | 0 / 0 |
OMIM | preferred title | UniProt |
---|---|---|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P14416
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#606798 | Blepharospasm, benign essential |
P21918
|
#114500 | Colorectal cancer; crc |
P84022
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#133239 | Esophageal cancer |
P04637
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610424 | Hepatitis b virus, susceptibility to |
P01375
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P04637
|
#611162 | Malaria, susceptibility to |
P01375
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#159900 | Myoclonic dystonia |
P14416
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607507 | Psoriatic arthritis, susceptibility to |
P01375
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00079 | Asthma |
P01375
(related)
|
H00080 | Systemic lupus erythematosus |
P01375
(related)
P01375 (marker) |
H00083 | Allograft rejection |
P01375
(related)
|
H00084 | Graft-versus-host disease |
P01375
(related)
P01375 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00125 | Fabry disease |
P06280
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |